Scopus BioPharma Announces Pricing of Initial Public Offering

Scopus BioPharma intends to use the proceeds of the offering principally to further development of the company's lead drug candidate, a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. About Scopus BioPharma Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics capitalizing on groundbreaking scientific and medical discoveries from leading research and academic institutions.  The company's lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers.  The company is also developing additional new chemical entities to treat other serious diseases with significant unmet medical needs, including systemic sclerosis.
（以上内容由医药魔方AI生成）